TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Telix (TLX) Facing Securities Class Action Lawsuit Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain – Hagens Berman

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Reed Kathrein
Telix (TLX) Facing Securities Class Action Lawsuit Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain – Hagens Berman

Telix Pharmaceuticals is facing a securities class action lawsuit alleging misleading disclosures about drug development progress and manufacturing compliance, following an SEC subpoena and FDA Complete Response Letter that caused significant stock decline.

Insights
TLX   negative

Company facing lawsuit over alleged material misstatements about drug development progress, regulatory compliance issues, and undisclosed manufacturing deficiencies that led to significant stock price drop